Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Across the recent three months, 4 analysts have shared their insights on Envista Holdings (NYSE:NVST), expressing a variety of opinions spanning from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 1 | 2 | 0 | 1 |
Last 30D | 0 | 0 | 0 | 0 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 0 |
2M Ago | 0 | 1 | 2 | 0 | 1 |
3M Ago | 0 | 0 | 0 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $20.12, along with a high estimate of $23.00 and a low estimate of $17.50. A decline of 22.62% from the prior average price target is evident in the current average.
An in-depth analysis of recent analyst actions unveils how financial experts perceive Envista Holdings. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Nathan Rich | Goldman Sachs | Lowers | Sell | $17.50 | $20.00 |
Rachel Vatnsdal | JP Morgan | Lowers | Overweight | $23.00 | $29.00 |
Jeff Johnson | Baird | Lowers | Neutral | $19.00 | $22.00 |
Erin Wright | Morgan Stanley | Lowers | Equal-Weight | $21.00 | $33.00 |
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Envista Holdings's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on Envista Holdings analyst ratings.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company's Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company's Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Challenges: Envista Holdings's revenue growth over 3 months faced difficulties. As of 31 March, 2024, the company experienced a decline of approximately -0.57%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 3.78%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Envista Holdings's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 0.57%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Envista Holdings's ROA stands out, surpassing industry averages. With an impressive ROA of 0.36%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.4, Envista Holdings adopts a prudent financial strategy, indicating a balanced approach to debt management.
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: NVST